Croda International PLC

M&A Activity • Dec 31, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7757L

Croda International PLC

31 December 2018

Croda International Plc ("Croda")

Acquisition of leading global vaccine adjuvant specialist

Further to the announcement on 17 December 2018, Croda has now completed the acquisition of Brenntag Biosector A/S ('Biosector') from Brenntag Nordic A/S on 28 December 2018.  Biosector is a specialist in the manufacture and supply of adjuvants serving both the human and veterinary vaccine markets.  

-ENDS-

For enquiries contact:

Investors:	Conleth Campbell, VP Investor Relations, Croda	+44 1405 860551
Press:	Charlie Armitstead, Teneo	+44 7703 330269

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ACQFKKDQDBDBDBN